Daniela Risso
Turin, 10126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CytoSorb in burn patients with septic shock and acute kidney injury on continuous kidney replacement therapy efficiently reduces the levels of Gram-negative-derived quorum-sensing molecules associated with lactate increases.
Journal: Burns : journal of the International Society for Burn Injuries
Published: April 11, 2026
Clinical outcomes of bromelain-based enzymatic debridement (NexoBrid®): evidence from the Italian National Burn Database.
Journal: Burns : journal of the International Society for Burn Injuries
Published: November 10, 2025
LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter Baumannii.
Journal: Antibiotics (Basel, Switzerland)
Published: March 20, 2025
Profiling of miRNAs Contained in Circulating Extracellular Vesicles and Associated with Sepsis Development in Burn Patients: A Proof-of-Concept Study.
Journal: International journal of molecular sciences
Published: December 30, 2024
First case of Chryseobacterium gallinarum bloodstream infection: a diagnostic and therapeutic challenge for an emerging pathogen.
Journal: The new microbiologica
Published: January 22, 2024
Use of Integra dermal regeneration template in burn patients: An Italian expert consensus Delphi study.
Journal: Burns : journal of the International Society for Burn Injuries
Published: December 24, 2023
CytoSorb® in burn patients with septic shock and Acute Kidney Injury on Continuous Kidney Replacement Therapy is associated with improved clinical outcome and survival.
Journal: Burns : journal of the International Society for Burn Injuries
Published: November 04, 2023
Colistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study.
Journal: International journal of general medicine
Published: January 12, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026